Sponsored content from Huge Alerts 
BioStem Technologies (BSEM) Rockets Toward Nasdaq with Record Earnings, Transformational $40M Acquisition, and High-Margin Growth Signaling a $25.50 Upside! BioStem Technologies, Inc. (OTCQB: BSEM) is turning heads in the regenerative medicine space with seven consecutive profitable quarters, blockbuster gross margins hitting 97%, and a bold $40 million acquisition of BioTissue Holdings’ surgical and wound care business. This move instantly expands BSEM’s footprint into higher-acuity care—hospitals, outpatient centers, and ambulatory surgery facilities—while adding established products like Neox® and Clarix®. The acquisition contributes nearly $29 million in revenue from 2025 alone, diversifying the company’s revenue streams and positioning it for a major growth phase in 2026. Beyond strategic expansion, BSEM continues to deliver robust earnings performance. Despite transitional macro pressures and one-time GAAP adjustments, quarterly revenue reached $10.1 million, adjusted EBITDA stayed positive at $3.4 million, and cash remained strong at ~$16 million post-acquisition. With Nasdaq uplisting preparations well underway, including audited 2024–2025 financials and KPMG review, the company is primed to attract institutional investors, improve liquidity, and unlock higher valuation multiples. Analysts see upside to $25.50, highlighting BSEM’s rare combination of profitability, clinical validation, and now expanded commercial reach. Learn why BSEM is on the fast track to becoming a small-cap MedTech standout!
Additional Reading from MarketBeat Alphabet Has Fallen 16% From Its Highs: Panic or Opportunity?Author: Ryan Hasson. Publication Date: 3/27/2026. 
Key Points - Alphabet has fallen almost 20% from its record high and broken below key $300 support, but the higher-timeframe uptrend remains intact.
- Fundamentals have rarely been stronger, with Q4 EPS and revenue both beating estimates.
- Despite the selloff, 46 of 51 analysts rate GOOGL a Buy, with a consensus price target of $367.18, implying nearly 26% upside.
- Special Report: Do this before SpaceX IPOs or be sorry
   Shares of Alphabet (NASDAQ: GOOGL), last year's top-performing Magnificent Seven stock, have sold off sharply from their record February high. The stock has declined by almost 20%, entering correction territory. In late March it broke below the key $300 support level, signaling a potential short-term momentum shift.
A jury's March 25 ruling added to the negative sentiment, finding its subsidiary YouTube liable in a social media addiction case and ordering a $3 million payment. That amount is negligible relative to a company with a market value in the trillions. Still, the headlines haven't helped. With the stock in correction territory, investors may be asking a fair question: Is it time to sell, or is this the buying opportunity patient investors have been waiting for? Correction Territory, But the Higher-Timeframe Trend Remains Intact From a technical perspective, this looks like a pullback and correction within a broader, higher-timeframe uptrend. On the weekly chart, the stock remains in a firm uptrend, and the current decline represents the first major pullback and retest since the breakout in July of last year. With the stock now below $300, the next potential area of support is around $280, where Alphabet spent several weeks consolidating in November. If the correction accelerates alongside broader market weakness, the final and most critical support zone would be the 200-day Simple Moving Average (SMA), currently near $260. That level would represent a meaningful, lower-risk area to watch closely for signs of stabilization and potential re-entry. The Fundamentals Have Rarely Been Stronger If the technical picture calls for patience, the fundamentals provide conviction. Just over a month ago, Alphabet reported its Q4 and full-year 2025 results, and the numbers were exceptional across the board. For the third consecutive quarter, the company beat both earnings and revenue expectations, surpassing $400 billion in annual revenue for the first time in company history. Earnings per share (EPS) came in at $2.82, ahead of the $2.59 consensus estimate. Revenue reached $113.83 billion, topping forecasts of $111.43 billion. For the full year, Alphabet generated $402.8 billion in revenue and $10.81 in EPS, reflecting year-over-year growth of 17% and 34%, respectively. Google Cloud continues to be the standout growth driver. Fourth-quarter cloud revenue reached $17.66 billion, up 48% year over year and well above estimates. On an annualized basis, Google Cloud has now surpassed a $70 billion revenue run rate. Cloud backlog surged 55% quarter over quarter to $240 billion, up from $155 billion the prior quarter, providing exceptional forward visibility. The core advertising business remains resilient, too. Search revenue rose 17% year over year in Q4, demonstrating that AI disruption concerns have yet to materially affect Google's most important revenue engine. YouTube generated more than $60 billion in combined advertising and subscription revenue in 2025, while Alphabet now boasts 325 million paid consumer subscriptions across its platforms. On the AI front, Gemini surpassed 750 million monthly active users, with over 10 billion tokens processed per minute through direct API usage, reflecting rapid enterprise and developer adoption. Analysts and Institutions Aren't Worried Despite the selloff, Wall Street sentiment toward the tech giant remains largely bullish. Of the 51 analysts covering the stock, 46 have assigned Buy ratings, resulting in a consensus Moderate Buy. The consensus price target of $367.18 implies nearly 26% upside from current levels, a move that would take the stock to new all-time highs. Institutional flows tell the same story. Over the prior 12 months there have been roughly $164 billion in inflows versus $82 billion in outflows, a significant net inflow that reflects deep and sustained confidence in Alphabet's execution, fundamentals and long-term positioning. | 
No comments:
Post a Comment